Amneal Pharmaceuticals (AMRX) market cap

Market cap today
$7.36B

Amneal Pharmaceuticals (AMRX) has a market cap of $7.36B. At the end of fiscal 2025 (December 31, 2025) its market cap was $4.09B. That is 67.2% higher than the $2.45B of fiscal 2024. Today's figure is 79.8% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 07:33 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$7.36B
Market cap, fiscal 2025
$4.09B
Change on fiscal 2024
+67.2%
Growth, 5 years
+43.2% a year
Highest on record
$4.09Bfiscal 2025
Lowest on record
$300.38Mfiscal 2022
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Amneal Pharmaceuticals market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 43.2% a year. Across the 8 fiscal year-ends on record (2018–2025), the highest was $4.09B in fiscal 2025 and the lowest $300.38M in fiscal 2022.

History · 8 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Amneal Pharmaceuticals market cap, year by year

Amneal Pharmaceuticals (AMRX) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$7.36B—$21.12—
2025$4.09B 67.2% up$12.60324.81M
2024$2.45B 128.9% up$7.92308.98M
2023$1.07B 255.9% up$6.07176.14M
2022$300.38M 58.7% down$1.99150.94M
2021$727.22M 6.9% up$4.79151.82M
2020$680.53M 6.9% up$4.57148.91M
2019$636.75M 63.0% down$4.82132.11M
2018$1.72B—$13.53127.25M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of Amneal Pharmaceuticals and comparable companies
CompanyMarket cap
ABIVAX ABVX$7.19B
Amneal Pharmaceuticals AMRX$7.36B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on AMRX

Amneal Pharmaceuticals, figure by figure

Amneal Pharmaceuticals (AMRX) overview: price, valuation and scorecardAll health care companies by market value

Amneal Pharmaceuticals market cap: questions and answers

What is Amneal Pharmaceuticals's market cap?

Amneal Pharmaceuticals (AMRX) has a market cap of $7.36B. At the end of fiscal 2025 (December 31, 2025) its market cap was $4.09B. That is 67.2% higher than the $2.45B of fiscal 2024.

What is the growth rate of Amneal Pharmaceuticals's market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 43.2% a year.

What are the highest and lowest market cap figures on record for Amneal Pharmaceuticals?

Across the 8 fiscal year-ends on record (2018–2025), the highest was $4.09B in fiscal 2025 and the lowest $300.38M in fiscal 2022.

How is Amneal Pharmaceuticals's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Amneal Pharmaceuticals (AMRX) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/AMRX/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.